-
1
-
-
72149093510
-
Mitochondria, oxidative metabolism and cell death in stroke
-
Sims N.R., Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010, 1802:80-91.
-
(2010)
Biochim Biophys Acta
, vol.1802
, pp. 80-91
-
-
Sims, N.R.1
Muyderman, H.2
-
2
-
-
43049135853
-
Stroke
-
Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
-
(2008)
Lancet
, vol.371
, pp. 1612-1623
-
-
Donnan, G.A.1
Fisher, M.2
Macleod, M.3
Davis, S.M.4
-
3
-
-
20744447947
-
Stroke epidemiology in the developing world
-
Feigin V.L. Stroke epidemiology in the developing world. Lancet 2005, 365:2160-2161.
-
(2005)
Lancet
, vol.365
, pp. 2160-2161
-
-
Feigin, V.L.1
-
4
-
-
33645830470
-
Toward a multimodal neuroprotective treatment of stroke
-
Rogalewski A., Schneider A., Ringelstein E.B., Schabitz W.R. Toward a multimodal neuroprotective treatment of stroke. Stroke 2006, 37:1129-1136.
-
(2006)
Stroke
, vol.37
, pp. 1129-1136
-
-
Rogalewski, A.1
Schneider, A.2
Ringelstein, E.B.3
Schabitz, W.R.4
-
5
-
-
0028783948
-
-
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM
-
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM 1995;333:1581-7.
-
(1995)
, vol.333
, pp. 1581-7
-
-
-
6
-
-
5444236498
-
Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy
-
Heuschmann P.U., Kolominsky-Rabas P.L., Roether J., et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA 2004, 292:1831-1838.
-
(2004)
JAMA
, vol.292
, pp. 1831-1838
-
-
Heuschmann, P.U.1
Kolominsky-Rabas, P.L.2
Roether, J.3
-
7
-
-
67650070650
-
Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia
-
Liu W., Hendren J., Qin X.J., Liu K.J. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Stroke 2009, 40:2526-2531.
-
(2009)
Stroke
, vol.40
, pp. 2526-2531
-
-
Liu, W.1
Hendren, J.2
Qin, X.J.3
Liu, K.J.4
-
8
-
-
2442462438
-
Extension of ischemic therapeutic time window by a free radical scavenger, edaravone, reperfused with tPA in rat brain
-
Zhang W., Sato K., Hayashi T., et al. Extension of ischemic therapeutic time window by a free radical scavenger, edaravone, reperfused with tPA in rat brain. Neurol Res 2004, 26:342-348.
-
(2004)
Neurol Res
, vol.26
, pp. 342-348
-
-
Zhang, W.1
Sato, K.2
Hayashi, T.3
-
9
-
-
34247844511
-
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology
-
Adams H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:1655-1711.
-
(2007)
Stroke
, vol.38
, pp. 1655-1711
-
-
Adams, H.P.1
del Zoppo, G.2
Alberts, M.J.3
-
10
-
-
66749132080
-
The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells
-
Kikuchi K., Kawahara K., Tancharoen S., et al. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. J Pharmacol Exp Ther 2009, 329:865-874.
-
(2009)
J Pharmacol Exp Ther
, vol.329
, pp. 865-874
-
-
Kikuchi, K.1
Kawahara, K.2
Tancharoen, S.3
-
11
-
-
70549090013
-
Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4
-
Kikuchi K., Tancharoen S., Matsuda F., et al. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4. Biochem Biophys Res Commun 2009, 390:1121-1125.
-
(2009)
Biochem Biophys Res Commun
, vol.390
, pp. 1121-1125
-
-
Kikuchi, K.1
Tancharoen, S.2
Matsuda, F.3
-
12
-
-
2542436923
-
Research and development of the free radical scavenger edaravone as a neuroprotectant
-
[in Japanese]
-
Watanabe T., Tanaka M., Watanabe K., Takamatsu Y., Tobe A. Research and development of the free radical scavenger edaravone as a neuroprotectant. Yakugaku Zasshi 2004, 124:99-111. [in Japanese].
-
(2004)
Yakugaku Zasshi
, vol.124
, pp. 99-111
-
-
Watanabe, T.1
Tanaka, M.2
Watanabe, K.3
Takamatsu, Y.4
Tobe, A.5
-
13
-
-
0037229213
-
-
The Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis
-
The Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222-9.
-
(2003)
, vol.15
, pp. 222-9
-
-
-
14
-
-
26444613280
-
Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain
-
Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005, 36:2220-2225.
-
(2005)
Stroke
, vol.36
, pp. 2220-2225
-
-
Zhang, N.1
Komine-Kobayashi, M.2
Tanaka, R.3
Liu, M.4
Mizuno, Y.5
Urabe, T.6
-
15
-
-
77249125873
-
Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy
-
Unno Y., Katayama M., Shimizu H. Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy. Clin Drug Investig 2010, 30(3):143-155.
-
(2010)
Clin Drug Investig
, vol.30
, Issue.3
, pp. 143-155
-
-
Unno, Y.1
Katayama, M.2
Shimizu, H.3
-
16
-
-
57449103131
-
The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator
-
Lapchak P.A., Zivin J.A. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator. Exp Neurol 2009, 215:95-100.
-
(2009)
Exp Neurol
, vol.215
, pp. 95-100
-
-
Lapchak, P.A.1
Zivin, J.A.2
-
17
-
-
34547574317
-
Neuroprotective effects of free radical scavengers in stroke
-
Wang C.X., Shuaib A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging 2007, 24:537-546.
-
(2007)
Drugs Aging
, vol.24
, pp. 537-546
-
-
Wang, C.X.1
Shuaib, A.2
-
18
-
-
33745955359
-
Therapeutic strategies for the treatment of stroke
-
Green A.R., Shuaib A. Therapeutic strategies for the treatment of stroke. Drug Discov Today 2006, 11:681-693.
-
(2006)
Drug Discov Today
, vol.11
, pp. 681-693
-
-
Green, A.R.1
Shuaib, A.2
-
19
-
-
0037039233
-
The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke
-
van der Worp H.B., Kappelle L.J., Algra A., et al. The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke. Neurology 2002, 58:133-135.
-
(2002)
Neurology
, vol.58
, pp. 133-135
-
-
van der Worp, H.B.1
Kappelle, L.J.2
Algra, A.3
-
20
-
-
34547795720
-
NXY-059 for the treatment of acute ischemic stroke
-
Shuaib A., Lees K.R., Lyden P., et al. NXY-059 for the treatment of acute ischemic stroke. NEJM 2007, 357:562-571.
-
(2007)
NEJM
, vol.357
, pp. 562-571
-
-
Shuaib, A.1
Lees, K.R.2
Lyden, P.3
-
22
-
-
60549111009
-
Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator
-
Yagi K., Kitazato K.T., Uno M., et al. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke 2009, 40:626-631.
-
(2009)
Stroke
, vol.40
, pp. 626-631
-
-
Yagi, K.1
Kitazato, K.T.2
Uno, M.3
-
23
-
-
34250760916
-
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases
-
Higashi Y., Jitsuiki D., Chayama K., Yoshizumi M. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2006, 1:85-93.
-
(2006)
Recent Pat Cardiovasc Drug Discov
, vol.1
, pp. 85-93
-
-
Higashi, Y.1
Jitsuiki, D.2
Chayama, K.3
Yoshizumi, M.4
-
24
-
-
33746549327
-
Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury
-
Yoshida H., Yanai H., Namiki Y., Fukatsu-Sasaki K., Furutani N., Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006, 12:9-20.
-
(2006)
CNS Drug Rev
, vol.12
, pp. 9-20
-
-
Yoshida, H.1
Yanai, H.2
Namiki, Y.3
Fukatsu-Sasaki, K.4
Furutani, N.5
Tada, N.6
-
25
-
-
39349091206
-
Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage
-
Nakamura T., Kuroda Y., Yamashita S., et al. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke 2008, 39:463-469.
-
(2008)
Stroke
, vol.39
, pp. 463-469
-
-
Nakamura, T.1
Kuroda, Y.2
Yamashita, S.3
-
26
-
-
0031446258
-
General pharmacological studies of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel radical scavenging agent
-
Ando K., Nishi H., Watanabe T., et al. General pharmacological studies of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel radical scavenging agent. Jpn Pharmacol Ther 1997, 25(Suppl.):S1723-S1753.
-
(1997)
Jpn Pharmacol Ther
, vol.25
, Issue.SUPPL.
-
-
Ando, K.1
Nishi, H.2
Watanabe, T.3
|